Author/Authors :
Hossein Vahidi Department of Pharmaceutical Biotechnology - School of Pharmacy - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Nafissi-Varcheh, Nastaran Department of Pharmaceutical Biotechnology - School of Pharmacy - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Kazemi, Bahram Cellular and Molecular Biology Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Aboofazeli, Reza Department of Pharmaceutics - School of Pharmacy - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Shahhosseini, Soraya Department of Pharmaceutical Chemistry - School of Pharmacy - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Tabarzad, Maryam Protein Technology Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract :
Protein specific aptamers are highly applicable affinity ligands in different fields of research
and clinical applications. They have been developed against various targets, in particular, biomacromolecules
such as proteins. Among human proteins, the coagulation factors are the most
attractive targets for aptamer selection and their specific aptamers have valuable characteristics
in therapeutic and analytical applications. In this study, a plasma derived coagulation factor
VIII was considered as the protein target for DNA aptamer selection using size exclusion
chromatography-SELEX. Potential aptameric oligonucleotides with high affinity and specificity
were achieved during eight rounds of selection. Binding affinity constant of selected aptamer
and aptameric enriched pool were in nanomolar range that was comparable to monoclonal
antibodies. Further improvement studies can result in aptamers that are more promising as an
industrial affinity ligand for the purification of anti-hemophilia factor from plasma source.
Keywords :
SELEX , Size Exclusion Chromatography , Affinity Ligands , Coagulation Factor VIII , Protein , Aptamer